Literature DB >> 26348216

Releasing the Brakes on Cancer Immunotherapy.

Antoni Ribas1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26348216     DOI： 10.1056/NEJMp1510079

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  76 in total

1.  Is allogeneic transplant for solid tumors still alive?

Authors:  M Bregni; M Badoglio; P Pedrazzoli; F Lanza
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

Review 2.  Integrative Pharmacology: Advancing Development of Effective Immunotherapies.

Authors:  Mohammad Tabrizi; Daping Zhang; Vaishnavi Ganti; Glareh Azadi
Journal:  AAPS J       Date:  2018-04-27       Impact factor: 4.009

Review 3.  Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.

Authors:  Zulmarie Perez Horta; Jacob L Goldberg; Paul M Sondel
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

Review 4.  Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis.

Authors:  Tomohiro F Nishijima; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss
Journal:  Oncologist       Date:  2017-03-08

5.  Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Authors:  Catherine S Grasso; Marios Giannakis; Daniel K Wells; Tsuyoshi Hamada; Xinmeng Jasmine Mu; Michael Quist; Jonathan A Nowak; Reiko Nishihara; Zhi Rong Qian; Kentaro Inamura; Teppei Morikawa; Katsuhiko Nosho; Gabriel Abril-Rodriguez; Charles Connolly; Helena Escuin-Ordinas; Milan S Geybels; William M Grady; Li Hsu; Siwen Hu-Lieskovan; Jeroen R Huyghe; Yeon Joo Kim; Paige Krystofinski; Mark D M Leiserson; Dennis J Montoya; Brian B Nadel; Matteo Pellegrini; Colin C Pritchard; Cristina Puig-Saus; Elleanor H Quist; Ben J Raphael; Stephen J Salipante; Daniel Sanghoon Shin; Eve Shinbrot; Brian Shirts; Sachet Shukla; Janet L Stanford; Wei Sun; Jennifer Tsoi; Alexander Upfill-Brown; David A Wheeler; Catherine J Wu; Ming Yu; Syed H Zaidi; Jesse M Zaretsky; Stacey B Gabriel; Eric S Lander; Levi A Garraway; Thomas J Hudson; Charles S Fuchs; Antoni Ribas; Shuji Ogino; Ulrike Peters
Journal:  Cancer Discov       Date:  2018-03-06       Impact factor: 39.397

6.  Effects of Affordable Care Act Marketplaces and Medicaid Eligibility Expansion on Access to Cancer Care.

Authors:  John A Graves; Katherine Swartz
Journal:  Cancer J       Date:  2017 May/Jun       Impact factor: 3.360

Review 7.  Immunotherapy Advances in Urothelial Carcinoma.

Authors:  Rohit K Jain; Travis Snyders; Lakshminarayanan Nandagopal; Rohan Garje; Yousef Zakharia; Shilpa Gupta
Journal:  Curr Treat Options Oncol       Date:  2018-12-15

Review 8.  Opportunities and challenges in combination gene cancer therapy.

Authors:  Kent L Nastiuk; John J Krolewski
Journal:  Adv Drug Deliv Rev       Date:  2015-12-23       Impact factor: 15.470

Review 9.  Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.

Authors:  Anne M Macpherson; Simon C Barry; Carmela Ricciardelli; Martin K Oehler
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

Review 10.  Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers.

Authors:  Arun Rajan; Chul Kim; Christopher R Heery; Udayan Guha; James L Gulley
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.